1. Ernster L, Dallner G: Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995;1271: 195-204.

2. Alleva R, Tomasetti M y col.: The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfraction. Proc Natl Acad Sci USA 1995;92: 9388-9391.

2. Weber C, Jakobsen TS y col.: Effect of dietary coenzyme Q10 as an antioxidant in human plasma. Mol Aspect Med 1994;15(suppl): S97-S102.

4. Tomono Y, Hasegawa J, Seki T y col.: Pharmacokinetic study of deuterium-labeled coenzyme Q10 in humans. Int J Pharmacol Therap Toxicol 1986;24: 536-541.

5. Nakamura T, Sanma H y col.: Transfer of exogenous coenzyme Q10 to the inner membrane of heart mitochondria in rats. In: Biomedical and Clinical Aspects of Coenzyme Q, Vol 2. 1980 Elsevier/North Holland Biomedical Press.

6. Aberg EL, Aberg F y col.: Distribution and redox states of ubiquinones in rat and human tissues. Arch Biochem Biophys 1992;295: 230-234.

7. Mitchel P: Protonmotive redox mechanism of the cytochrome b-c1 complex in the respiratory chain: protonmotive ubiquinone cycle. FEBS Lett 1975 Aug 1;56(1): 1-6.

8. Mohr D, Bowry VW y col.: Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim Biophys Acta 1992;1126: 247-254.

9. Frei B, Kim MC, Ames BN: Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA 1990;87: 4879-4883.

10. Forsmark-Andree P, Ernster L: Evidence for a protective effect of endogenous ubiquinol against oxidative damage to mitochondrial protein and DNA during lipid peroxidation. Mol Asp Med1994;15: (Suppl)S73-S81.

11. Yokoyama H, Lingle DM, Crestanello JA y col.: Coenzyme Q10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect. Surgery 1996;120: 189-196.

12. Matasushima T, Sueda T y col.: Protection by coenzyme Q10 of canine myocardial reperfusion injury after preservation. J Thorac Cardiovasc Surg 1992;103: 945-951.

13. Nayler WG: The use of coenzyme Q10 to protect ischemic heart muscle. In: Biomedical and Clinical Aspects of Coenzyme Q10.Yamamura Y, Folkers K, Ito (Eds.) Elsevier/North Holland Press;NY. 1980;2: 409-424.

14. Whitman GJ, Niibori K, Yokoyama H y col.: The mechanism of coenzyme Q10 as a therapy for myocardial ischemia reperfusion injury. Mol Asp Med 1997;18 Suppl: S195-S203.

15. Hano O, Thompson Gorman SL, Zweier JL y col.: Coenzyme Q10 enhances cardiac functional and metabolic recovery and reduces Ca2+ overload during postischemic reperfusion. Am J Physiol 1994;266 (6Pt2): H2174-H2181.

16. Matsumoto H, Miyawaki F y col.: Effect of Coenzyme Q10 pretreatment on myocardial preservation heart transplantation. 1984;3: 160-165.

17. Mullany CJ, Darling GE, Pluth JR y col.: Early and late results after isolated coronary artery bypass surgery in 159 patients aged 80 years and older. Circulation 1990;82 (5 Suppl): IV229-IV236.

18. Folkers K, Vadhanavikit S, Mortensen SA: Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci USA 1985;82: 901-904.

19. Mortensen SA, Vadhanavikit S, Muratsu K y col.: Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure. Int J Tissue Reac 1990;12: 155-162.

20. Langsjoen PH, Vadhanavikit S, Folkers K: Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. Proc Natl Acad Sci USA 1985;82: 4240-4244.

21. Judy WV, Folkers K, Hall JH: Improved long term survival in coenzyme Q10 treated chronic heart failure patients compared to conventionally treated patients. In Biomedical and Clinical Aspects of Coenzyme Q10, eds Folkers K, Littarru GP, and Yamagami T. 1991;6: 291-298. Elsevier, Amsterdam.

22. Hofman- Bang C, Rehnqvist N y col.: Coenzyme Q10 as an adjunctive in treatment of congestive heart failure. JACC 1992;19: 216A.

23. Folkers K, Langsjoen PH, Langsjoen P: Therapy with coenzyme Q10 in patients with heart failure who are eligible or ineligible for a transplant. Biochem Biophys Res Comm 1992;182: 247-253.

24. Schested P, Heidt P y col.: Normal levels of coenzyme Q10 in patients awaiting cardiac transplantation. Transpl Proceed 1993;25: 2365-2367.

25. Kamikawa T, Kobayashi A, Yamashita T y col.: Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. Am J Cardiol 1985;56: 247-251.

26. Atar D, Mortensen SA, Flachs H y col.: Coenzyme Q10 protects ischemic myocardium in an open chest swine model. Clin Invest 1993;71(8 Suppl): S103-S111.

27. Birnbaum Y, Hale SL, Kloner RA: The effect of coenzyme Q10 on infarct size in a rabbit model of ischemia/reperfusion. Cardiovasc Res 1996;32: 861-868.

28. Tanaka J, Tominaga R y col.: Coenzyme Q10. The prophylactic effect on low cardiac output following cardiac valve replacement. Ann Thorac Surg 1982;33: 145-151.

29. Sunamori M, Tanak H, Maruyama T y col.: Clinical experience of coenzyme Q10 to enhance intraoperative myocardial protection in coronary artery revascularization. Cardiovasc Drugs Ther 1991;5: S297-300.

30. Judy WV, Stogsdill WW y col.: Myocardial preservation by therapy with coenzyme Q10 during heart surgery. Clin Investig 1993;71: S155-161.

31. Chello M, Mastroroberto P y col.: Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting. Ann Thorac Surg 1994;58: 1427-1432.

32. Taggart DP, Jenkins M y col.: Effects of short term supplementation with coenzyme Q10 on myocardial protection during cardiac operations. Ann Thorac Surg 1996;61: 829-833.